TS
AEON.WS

Thomas Steyer’s AEON Biopharma Inc AEON.WS Stock Holding History

Thomas Steyer’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,995
Closed -$72.5K – 195
2024
Q1 		$72.5K Hold
49,995
– – ﹤0.01% 159
2023
Q4 		$4.37K Hold
49,995
– – ﹤0.01% 155
2023
Q3 		$7.5K Hold
49,995
– – ﹤0.01% 157
2023
Q2 		$4.5K Hold
49,995
– – ﹤0.01% 166
2023
Q1 		$2.75K Hold
49,995
– – ﹤0.01% 190
2022
Q4 		$2.28K Hold
49,995
– – ﹤0.01% 232
2022
Q3 		$4K Hold
49,995
– – ﹤0.01% 299
2022
Q2 		$7K Hold
49,995
– – ﹤0.01% 307
2022
Q1 		$16K Hold
49,995
– – ﹤0.01% 316
2021
Q4 		$25K Hold
49,995
– – ﹤0.01% 296
2021
Q3 		$29K Hold
49,995
– – ﹤0.01% 295
2021
Q2 		$50K Buy
+49,995
New +$37.9K ﹤0.01% 289

Thomas Steyer's AEON.WS Position: Q2 2024 in Review

Thomas Steyer sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 49,995 shares — an estimated $72.5K sold.

Thomas Steyer first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $72.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Thomas Steyer reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Thomas Steyer sold 49,995 AEON Biopharma Inc shares in Q2 2024, an estimated $72.5K.
  • Thomas Steyer first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Thomas Steyer's AEON Biopharma Inc position peaked at $72.5K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.